CytoMed Therapeutics董事长将有效持股增加至21.95%

2025-10-22 20:46

CytoMed Therapeutics (NASDAQ:GDTC) said on Wednesday that its executive chairman and substantial shareholder, Peter Choo, has increased his shareholding in the company through recent open-market purchases of 105,824 shares.
This is on top of 187,500 shares, which he holds personally, bringing his personal stake in CytoMed to 2.50% as of today.
In addition, he is also a 55% shareholder of Glorious Finance and the sole shareholder of EP Capital, representing 2.28M shares, or 19.45% of the company.
In aggregate, he owns 2.39M shares, representing 21.95% of the company’s total outstanding shares.
CytoMed Therapeutics (NASDAQ:GDTC) shares were up more than 7% in premarket trading.

More on CytoMed Therapeutics